6Goodwin AM,Kitajewski J,D'Amore PA.Wnt1 and Wnt5a affect endothelial proliferation and capillary length;Wnt2 does not[J].Growth Factors,2007,25(1):25.
7Svirshchevskaya EV,Mariotti J,Wright MH,et al.Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity[J].BMC Cancer,2008,8(5):176.
8Gao X,Wen J,Zhang L,et al.Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus[J].J Biol Chem,2008,283(51):35679.
9Herranz H,Pérez L,Martín FA,et al.A Wingless and Notch double-repression mechanism regulates G1-S transition in the Drosophila wing[J].EMBO J,2008,27(11):1633.
10Collu GM,Brennan K.Cooperation between Wnt and Notch signalling in human breast cancer[J].Breast Cancer Res,2007,9(3):105.
3Salozhin S, Prokhorchuk E, Georgiev G. Methylation of DNA-one of the major epigenetic markers [ J ]. Biochemistry (Moscow), 2005, 70(5): 525-532.
4Santos K, Mazzola T, Carvalho H. The prima donna of epigenetics: The regulation of gene expression by DNA methylation[ J]. Brazilian journal of medical and biological research, 2005, 38(10): 1531-1541.
5Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction.'? [ J]. Nature Reviews Cancer, 2006, 6(2) : 107-116.
6Kogo R, Mimori K, Tanaka F, et al. Fbxo31 determines poor prognosis in esophageal squamous cell carcinoma[J]. International journal of oncology, 2011, 39( 1 ) : 155-159.
7Komatsu Y, Hibi K, Kodera Y, et al. Taosl, a novel marker for advanced esophageal squamous cell carcinoma [ J ]. Anticancer research, 2006, 26 (3A) : 2029-2035.
8Hong C, Bollen AW, Costello JF. The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas [ J]. Cancer research, 2003, 63 (22) : 7600-7605.
9Kenig A, Linhart T, Katrin S, et al. Nfat-induced histone acetylation relay switch promotes c-myc-dependent growth in pancreatic cancer cells [ J ]. Gastroenterology, 2010, 138(3) : 1189-1199. e1182.
10Sakata T, Ferdous G, Tsuruta T, et al. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer[ J]. Pathology international, 2009, 59(1) :7-18.
